SHARE

An initial purchase of the steroid dexamethasone, shown to be effective in treating severe or critical COVID-19 patients, will be made for up to 4.5 million people in low- and middle-income countries, agencies said.

The UN Children’s Fund (UNICEF) is negotiating the advance purchase under the deal led by UNITAID and Wellcome, as part of the World Health Organization’s plan to accelerate access to therapeutics, a joint statement said.

Researchers estimated that the drug would prevent one death for every eight patients treated while on breathing machines and one for every 25 patients on extra oxygen alone.

Al Jazeera News

SHARE

NO COMMENTS

LEAVE A REPLY